Archives

All posts by Cited in article

New research shows that states with legal recreational cannabis had fewer cases of lung injuries related to vaping than other states, according to a study published by JAMA Network Open on Monday. The researchers found no significant difference in the number of e-cigarette or vaping associated lung injury (EVALI) cases in states with legal medical marijuana compared to prohibition states.

To conduct the study, researchers conducted an analysis of data from the Centers for Disease Control and Prevention (CDC) on EVALI cases at the state level, including Washington, D.C. The data was evaluated in conjunction with population figures and information on the prevalence of e-cigarette use for each state.

The study revealed that states with legal recreational marijuana dispensaries had 1.7 cases of EVALI per million people while states that prohibit adult-use cannabis had 8.1 cases per million. States that have only legalized medical marijuana saw 8.8 EVALI cases per one million residents, which while higher than prohibition states was not statistically significant.

“The data suggest that EVALI cases were concentrated in states where consumers do not have legal access to recreational marijuana dispensaries,” the study’s authors wrote. “This association was not driven by state‐​level differences in e‑cigarette use, and

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

Cannabis retailers in Ontario were allowed to reopen for curbside pickup and deliver on Tuesday under an emergency order issued by the Alcohol and Gaming Commission of Ontario (AGCO). The move reverses an order issued by the province last week that deemed recreational marijuana shops nonessential businesses and directed them to close to help contain the spread of the COVID-19 coronavirus pandemic.

Under the temporary order, licensed recreational marijuana retailers will be permitted to take orders and process payments online or via telephone for home delivery or curbside pickup by customers. Sales will be permitted every day from the hours of 9 a.m. to 11 p.m. The temporary order does not change the cap on purchases that limits sales to 30 grams of dried cannabis or the equivalent per transaction.

Customers must pay for their orders in advance over the phone or online. When a customer arrives for curbside pickup, the order will be brought to them outside in the product’s original packaging. Payment onsite will not be permitted, and transactions must be captured on the retailer’s video surveillance system.

Emergency Order Reverses Previous Closure

Ontario’s emergency order marks the second time in less than a week that the provincial

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

In my ten years of advising and guiding cannabis companies from a corporate, transactional, and M&A perspective, and especially since 2012 (when Washington and Colorado legalized), every cannabis market in which I’ve worked has experienced a period of extensive business failures, consolidations, and market stress. And it’s that time now for California cannabis (and that was already happening before COVID-19 struck, which is actually a kind of economic shot in the arm for cannabis businesses, all of which have been deemed essential and are allowed to continue to operate). It’s been nearly two years of licensing, and in a strong local control market like California, it’s no surprise that many cannabis companies (of all sizes) are either going under or headed that way (and will still likely be so post-COVID-19 when the level of sales goes down again). What that means is that enterprising investors experienced with distressed assets have significant opportunities before them.

Many things are causing this uniform failure across California’s cannabis marketplace. The first is local control. To get a California cannabis license, your cannabis business must first secure local authorization to proceed. There are 482 cities in California and 58 counties. Every single one of

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

On March 31, 2020, Washington State Governor Jay Inslee signed HB 2870, which “creates a new social equity program that provides business opportunities to people from disproportionately-harmed communities so they can benefit economically from the cannabis industry and become a cannabis retailer.” We’ve covered the social equity program in Los Angeles pretty heavily, as our L.A. office has been working with applicants since the beginning, and in California, Oakland and San Francisco have also implemented social equity programs.

Washington, one of the first two states to legalize adult-use cannabis, is a relatively late adopter of a strategy for implementing such a program. However, according to HB 2870, the legislature is recognizing a truth that is being widely discussed:

… that individuals who have been arrested or incarcerated due to drug laws, and those who have resided in areas of high poverty, suffer long-lasting adverse consequences, including impacts to employment, business ownership, housing, health, and long-term financial well-being. The legislature also finds that family members, especially children, and communities of those who have been arrested or incarcerated due to drug laws, suffer from emotional, psychological, and financial harms as a result of such arrests and incarceration. The legislature further

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

It is with great sadness that we announce that Charlotte Figi, the namesake and inspiration behind the acclaimed CBD strain Charlotte’s Web, passed away yesterday at age 13.

Charlotte and her twin sister Chase were born on October 18, 2006 in Colorado. Charlotte had a seizure when she was three years old and was subsequently diagnosed with the rare and life-threatening seizure disorder known as Dravet syndrome. She was prescribed a variety of pharmaceuticals, but nothing seemed to work. Her seizures were constant and long-lasting. She was placed in hospice at age five.

Charlotte’s mother, Paige, refused to take her daughter’s diagnosis lying down. She researched her disorder, related disorders, and eventually found a Brazilian study about epilepsy and cannabidiol. In 2011, she embarked on a journey to get ahold of a supply of CBD and track down growers who cultivated it. At this point in time, CBD was rarely discussed, even in the cannabis space. But the stars aligned, and Paige was finally approached by professional cannabis grower Joel Stanley. They worked together to create a high-CBD, low-THC strain—when Paige administered the resulting oil, Charlotte went from having 300 seizures a week to a few episodes a month. It

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

Use your time indoors to cook some new recipes that can be fun as well.

The global coronavirus pandemic has introduced added stress and anxiety to most people’s already hectic lives. Vacation plans have been canceled, schools are out, and millions of people have been laid off, but many countries around the world are taking proactive steps to fight the spread of the respiratory virus by issuing a quarantine. It may be difficult for most people to stay home (especially if you’re living in a tiny studio apartment with one window), but it is the only way to reduce community spread, assist our healthcare workers, and ultimately save lives. Cooking is one activity that can help you to relax during this time, especially when you feel trapped at home. Here are some tasty cannabis infused meals you can make yourself.

– Read the entire article at Magnetic Mag.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

A bad situation in Ontario is now even worse.

There’s been nothing but bad news for Aurora Cannabis (NYSE:ACB) lately. The Canadian cannabis producer posted dismal fiscal 2020 Q2 results in February. Its longtime CEO stepped down. Aurora laid off staff. Its stock is down more than 60% year to date.

And now the picture for Aurora just got bleaker. One of the biggest problems for the company in 2019 became worse over the weekend.

– Read the entire article at The Motley Fool.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

Applications for medical marijuana cards have spiked in Massachusetts with the closure of the state’s adult-use cannabis dispensaries that was ordered to slow the spread of the deadly COVID-19 coronavirus. The increase in patient registrations comes after regulations that govern the medicinal cannabis program were relaxed in response to the outbreak.

When Massachusetts Gov. Charlie Baker ordered the closure of nonessential businesses in the state and issued a stay-at-home directive to residents last month, he said that medical marijuana dispensaries would be “treated for all intents and purposes the same way we treat healthcare operations” and allowed to remain open.

But that decision didn’t apply to the state’s recreational cannabis dispensaries, which were ordered to close along with other nonessential businesses on March 24 to help contain the spread of the virus. Baker cited the influx of traffic from neighboring states that do not have legal adult-use marijuana as the reason for the distinction. Cannabis dispensaries that sell both medical and recreational marijuana were directed to only serve registered patients.

To support social distancing measures, the Massachusetts Cannabis Control Commission (CCC) has modified some of the requirements to be certified as a medical marijuana patient, including allowing physicians to consult

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

In the few years, and especially since the U.S. government passed the 2018 Farm Bill, CBD products have exploded onto the global marketplace. Now that any kind of consumer product imaginable has been marketed with CBD additives—including things like sportswear, pillows, toothpaste, and even hand sanitizer—manufacturers are exploring less prominent cannabinoids to isolate and market in consumer products.

In this FREE Harris Bricken webinar at 12pm PST on Wednesday, April 29th, our cannabis and hemp attorneys, Daniel Shortt (Seattle, WA), Griffen Thorne (Los Angeles, CA), Nathalie Bougenies (Portland, OR) and Vince Sliwoski (Portland, OR) will discuss the latest trends in the developing cannabinoid market, including CBG, CBN, and others. We will also examine the approach to regulating hemp, marijuana, and their cannabinoids within state, federal and international frameworks. Domestically, we will look closely at the FDA, to highlight where we think states will go with regulating “new cannabinoids”. And finally, we will discuss intellectual property and a host of other commercial contract issues that are critical for cannabinoid product marketers, manufacturers, and sellers.

CBD is so 2019. Don’t forget to tune into our free webinar to learn about the hottest new trends in cannabinoids and cannabinoid products!

Register HERE

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

The U.S. Drug Enforcement Administration has removed the CBD pharmaceutical Epidiolex from the nation’s list of controlled substances, a move that should make it easier for patients to access the medication. Epidiolex is the only medication derived directly from cannabis that has been approved by the U.S. Food and Drug Administration for use in the United States.

The drug is a flavored oral solution with cannabidiol (CBD) that reduces seizures in children with epilepsy. The medicine, which is not psychoactive, also contains less than 0.1 percent THC. Epidiolex is produced by drug manufacturer GW Pharmaceutical at its facilities in the U.K.

After Epidiolex received FDA approval in June 2018, the drug was placed on Schedule V of the Controlled Substances Act (CSA). On Monday, GW was notified by the FDA that the drug is longer subject to the CSA, a change that goes into effect immediately.

“This notification from DEA fully establishes that EPIDIOLEX, the only CBD medicine approved by FDA, is no longer a controlled substance under the federal Controlled Substances Act,” said GW CEO Justin Gover in a press release.  “We would like to thank DEA for confirming the non-controlled status of this medicine. Importantly, the descheduling of

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest